[1] Schwartz,Michael W,Daniel P J.Diabetes,obesity,and the brain[J].Science,2005,307(5708):375-379.
[2] Klonoff D C,Buse J B,Nielsen L L,et al.Exenatide effects on diabetes,obesity,cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years[J].Current Medical Research and Opinion,2008,24(1):275-286.
[3] Baxter J D,Webb P.Thyroid hormone mimetics:potential applications in atherosclerosis,obesity and type 2 diabetes[J].Nature Reviews Drug Discovery,2009,8(4):308-320.
[4] Inoue K,Sawada T,Suge H,et al.Spouse concordance of obesity,blood pressures and serum risk factors for atherosclerosis[J].Journal of Human Hypertension,1996,10(7):455-459.
[5] Chrostowska M,Szyndler A,Hoffmann M,et al.Impact of obesity on cardiovascular health[J].Best Practice & Research Clinical Endocrinology & Metabolism,2013,27(2):147-156.
[6] Carpagnano G E,Resta O,Pergola G D,et al.The role of obstructive sleep apnea syndrome and obesity in determining leptin in the exhaled breath condensate[J].Journal of Breath Research,2010,4(3):036003.
[7] Olson A L,Zwillich C.The obesity hypoventilation syndrome[J].The American Journal of Medicine,2005,118(9):948-956.
[8] Akinnusi M E,Saliba R,Porhomayon J,et al.Sleep disorders in morbid obesity[J].European Journal of Internal Medicine,2012,23(3):219-226.
[9] Grunstein R,Wilcox I,Yang T S,et al.Snoring and sleep apnoea in men:association with central obesity and hypertension[J].International journal of obesity and related metabolic disorders.Journal of the International Association for the Study of Obesity,1993,17(9):533-540.
[10] Ji H,Wang J,Jing Y.Physiological functions application prospect of soybean isoflavone[J].Chinese Journal of Modern Drug Application,2011,5(16):128-129.
[11] Duncan A M,Underhill K E,Xu X,et al.Modest hormonal effects of soy isoflavones in postmenopausal women[J].The Journal of Clinical Endocrinology and Metabolism,1999,84(10):3479-3484.
[12] Ørgaard Anne,Jensen L.The effects of soy isoflavones on obesity[J].Experimental Biology and Medicine,2008,233:1066-1080.
[13] Bu L K D,Setchell E D,Lephart.Influenes of dietary soy isoflavones on metabolism but not nociception and stress hormone responses in ovariectomized female rats[Z].Reprod Bilo Endocrionol,2005,3:58.
[14] Yamakado M,Ishizaka Y,Takahashi E.Clinical study on the role of leptin and insulin resistance in the pathogenesis of obesity related hypertension[J].American Journal of Hypertension,2001,14(4):A222.
[15] Kohno D,Suyama S,Yada T.Leptin transiently antagonizes ghrelin and long-lastingly orexin in regulation of Ca2+ signaling in neuropeptide Y neurons of the arcuate nucleus[J].World Journal of Gastroenterology,2008,14(41):6347-6354.
[16] Erickson J C,Clegg K E,Palmiter R D.Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y[J].Nature,1996,381(6581):415-421.
[17] Paxinos,Watson G C.The rat brain in stereotaxic coordinates[M].Sydney:Elsevier Academic Press,2005.
[18] Goss A M,Darnell B E,Brown M A,et al.Longitudinal associations of the endocrine environment on fat partitioning in postmenopausal women[J].Obesity (Silver Spring,Md.),2012,20(5):939-944.
[19] Yüksel H,Odabasi A R,Demircan S,et al.Effects of postmenopausal hormone replacement therapy on body fat composition[J].Gynecological Endocrinology,2007,23(2):99-104.
[20] Rice S,Whitehead S A.Phytoestrogens oestrogen synthesis and breast cancer[J].The Journal of Steroid Biochemistry and Molecular Biology,2008,108(3/5):186-195.
[21] Pierroz D D,Ziotopoulou M,Ungsunan L,et al.Effects of acute and chronic administration of the melanocortin agonist MTⅡ in mice with diet-induced obesity[J].Diabetes,2002,51(5):1337-1345.
[22] Zhang Y,Scarpace P J.The role of leptin in leptin resistance and obesity[J].Physiology & Behavior,2006,88(3):249-256.
[23] Lin S,Storlien L H,Receptor H L,et al.POMC mRNA expression in the diet-induced obese mouse brain[J].Brain Research,2000,875(1/2):89-95.
[24] Burguera B,Couce M E,Long J,et al.The long form of the leptin receptor (OB-Rb) is widely expressed in the human brain[J].Neuroendocrinology,2000,71(3):187-195. |